Clostridium difficile: improving the prevention paradigm in healthcare settings. - Wikidata - wikimedia - TriplyDB

Clostridium difficile: improving the prevention paradigm in healthcare settings.

Clostridium difficile: improving the prevention paradigm in healthcare settings.

http://www.wikidata.org/entity/Q35222472

about

Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+): Characterization, Manufacture, Mechanisms of Action, and Quality Control of a Specific Probiotic Combination for Primary Prevention of Clostridi Determining the Long-term Effect of Antibiotic Administration on the Human Normal Intestinal Microbiota Using Culture and Pyrosequencing Methods.Fecal microbiota transplantation for Clostridium difficile infection: back to the future.Probiotics as adjunctive therapy for preventing Clostridium difficile infection - What are we waiting for?Economic burden of Clostridium difficile in five hospitals of the Florence health care system in Italy Primary prevention of Clostridium difficile infections - how difficult can it be?Clostridium difficile in the community: time to clean up?

P2860

Q27012496-6FE376A6-3AEC-4927-A8B3-CC0D55D89688 Q35617258-9BFAFB4E-E71F-43EB-98C8-DAF2B9D709E0 Q35660581-0ADAB247-409A-4AAD-AF89-F162ED648029 Q36018176-590B49AD-1276-41A4-940D-1CFACC7EFF9C Q36307202-0A9E6159-04F4-4356-A4A3-3EEE5CD90A0C Q38739075-3216BF95-01EF-433A-9288-5E9CB2F76D17 Q41715629-99EF9561-C922-4E88-A855-208CBC80F603

P2860

Clostridium difficile: improving the prevention paradigm in healthcare settings.

http://www.wikidata.org/entity/Q35222472

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Clostridium difficile: improving the prevention paradigm in healthcare settings.

@ast

Clostridium difficile: improving the prevention paradigm in healthcare settings.

@en

type

label

Clostridium difficile: improving the prevention paradigm in healthcare settings.

@ast

Clostridium difficile: improving the prevention paradigm in healthcare settings.

@en

prefLabel

Clostridium difficile: improving the prevention paradigm in healthcare settings.

@ast

Clostridium difficile: improving the prevention paradigm in healthcare settings.

@en

P1433

Q35222472-F5713006-8827-4BAF-9F02-6E625C5CA4EE

P1476

Q35222472-7B5A8B69-F3C6-4361-92A2-BA5A27E05734

P2093

Q35222472-C0749AB4-FA01-4ADD-BB9C-CD86DB647426

Q35222472-DF8768CD-68CF-48E9-86E3-2AC551A67DD1

Q35222472-F0F584B8-661B-4859-828D-E84B8D75CCFA

P2860

Q35222472-0051A3B7-3174-4C6E-B175-570DB3481899

Q35222472-019507E7-9534-4E4B-A4FA-A60B917472AC

Q35222472-036177D3-78E2-4C16-B486-F16FBB21DE0F

Q35222472-079311AD-E63A-4980-9B0B-6D4320051428

Q35222472-09DCDB55-2FB7-4CA5-8AA3-BD609181598E

Q35222472-0D034164-3C45-4F18-9FA4-ACA039E1DA9F

Q35222472-1031B52F-1510-4D84-AD42-CEC7133135D2

Q35222472-127C0437-0409-4092-A375-CBA6BA12D34C

Q35222472-16CAC712-CA5B-42B2-BC9E-FE8A0CC7A0CE

Q35222472-1C3BF80C-F291-4BE1-BEA2-D4072FD7C87C

P304

Q35222472-73D0F964-759A-4401-8D70-E54264949C08

P31

Q35222472-D5B87484-D3CC-463F-A780-6553CCF1A6E3

P356

Q35222472-7C52950A-310C-4180-A614-12AB71691644

P433

Q35222472-176DF0D4-1ACD-46C9-B575-03BBCED1CD8C

P478

Q35222472-30FF64FE-2326-4BC2-B4F1-6C2D70448197

P577

Q35222472-C1705382-4755-46DF-AAC6-2DDFE0B82A6C

P5875

Q35222472-596CD093-3102-4944-8EAF-1613CCF560BD

P698

Q35222472-DC75326A-7AE3-49F0-8AAA-B2B0404BBCCA

P921

Q35222472-D48ACF0F-C3D4-4CF9-9944-07C972313A77

P356

14787210.2014.942284

P1433

Expert Review of Anti-infective Therapy

P1476

Clostridium difficile: improving the prevention paradigm in healthcare settings.

@en

P2093

Angela Vassallo

http://www.w3.org/2001/XMLSchema#string

Ellie J C Goldstein

http://www.w3.org/2001/XMLSchema#string

Mai-Chi N Tran

http://www.w3.org/2001/XMLSchema#string

P2860

Pleiotropic effects of statins

Is primary prevention of Clostridium difficile infection possible with specific probiotics?

Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis

Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-analysis

Community-associated Clostridium difficile infection and antibiotics: a meta-analysis

Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis

Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial

The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing

Hospital epidemiology and infection control in acute-care settings.

Monitoring of stool microbiota in subjects with diarrhea indicates distortions in composition

P304

1087-1102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14787210.2014.942284

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264563430

http://www.w3.org/2001/XMLSchema#string

P698

25109301

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile